Café

© 2026 Longbridge｜Terms of Service Privacy Policy

XXII

XXII

4.3255.23%( +0.215 )

LongbridgeAI

22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review | XXII Stock News

StockTitan

May 12, 2026 at 04:50 AM

22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review | XXII Stock News

22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review | XXII Stock News

Login to unlock120characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

22nd Century

USXXII

+5.23%

First Trust NYSE Arca Biotech Index Fd

USFBT

Direxion S&P Biotech Bull 3X

USLABU